Catastrophic antiphospholipid antibody syndrome in systemic lupus erythematosus: An autopsy case report of a young woman

Internal Medicine

Volumn 39, Issue 10, 2000, Pages 856-859

  Mizuno, Reiko ^a,b   Fujimoto, Shinichi ^a   Fujimoto, Takashi ^a   Nishino, Toshihiko ^a   Shiiki, Hideo ^a   Hashimoto, Toshio ^a   Nakamura, Shinobu ^a   Dohi, Kazuhiko ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b First Dept of Internal Medicine   (Japan)

Author keywords

Anticardiolipin antibodies (aPL); Thrombotic thrombocytopenic purpura (TTP)

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BRAIN; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FATALITY; FEMALE; HUMAN; IMMUNOLOGY; MULTIPLE ORGAN FAILURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; TERMINAL DISEASE;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BRAIN; CATASTROPHIC ILLNESS; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; MULTIPLE ORGAN FAILURE;

EID: 0034303135     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.39.856     Document Type: Article

References (15)

1. Matsuura Y, Nawata Y, Miike S, et al. Lupus anticoagulants in patients with systemic lupus erythematosus. Ryumachi 36: 16-24, 1996.
2. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erytematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med 112: 682-698, 1990.
3. Harris EN, Baguley E, Asherson RA, et al. Clinical and serological features of the antiphospholipid syndrome (APS). Br J Rheumatol 26: 19, 1987 (Suppl 2).
4. Asherson RA. The catastrophic antiphospholipid syndrome. J Rheumatol 19: 508-512, 1992 (editorial).
5. Asherson RA, Piette J-C. The catastrophic antiphospholipid syndrome 1996: acute multi-organ failure associated with antiphospholipid antibodies: A review of 31 patients. Lupus 5: 414-417, 1996.
6. Asherson RA, Cervera R, Piette JC, et al. The catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine 77: 195-207, 1998 (Baltimore).
7. Asherson RA, Cervera R, Font J. Multiorgan thrombotic disorders in systemic lupus erytematosus: a common link?. Lupus 1: 199-203, 1992.
8. Tobelem G, Cariou R, Camez A. The lupus anticoaglant and its role in thrombosis. Blood Rev 1: 21-24, 1987.
9. Khamashta MA, Harris EN, Gharavi AE, et al. Immune mediated mechanism for thrombosis; antiphospholipid antibody binding to platelet membranes. Ann Rheum Dis 47: 849-854, 1988.
10. Golden BD, Belmont HM. The role of microvasculopathy in the catastrophic antiphospholipid syndrome: comment on the article by Neuwelt et al. Arthritis Rheum 41: 751-752, 1998 (letter; comment).
11. Belmont HM, Abramson SB, Lie JT. Pathology and pathogenesis of vascular injury in systemic lupus erythematosis. Arthritis Rheum 39: 9-22, 1996.
12. Furlan M, Robles R, Galbusera M, et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 339: 1578-1584, 1998 (see comment).
13. Holt CM, Lindsey N, Moult J, et al. Antibody-dependent cellular cytotoxicity of vascular endothelium: Characterization and pathogenic associations in systemic sclerosis.Clin Exp Immunol 78: 359-365, 1989.
14. Karmochkine M, Boffa MC, Piette JC, et al. Increase in plasma thrombomodulin in lupus erythematosus with antiphopholipid antibodies. Blood 79: 837-838, 1992 (letter).
15. Takahashi H, Hanano N, Wada K, et al. Circulating thrombomodulin in thrombotic thrombocytopenic purpura. Am J Haematol 38: 174-177, 1991.